All stock lists
MOLOGEN Lifescience AG (Frankfurt Stock Exchange:U1DA.F)
DE · Delayed Price · Currency is EUR
Financial Services · Asset Management
2.80+0.00 (+0.00%)
Insider Score
––Not scored
U1DA.F Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
U1DA.F Income Statement
| Fiscal Period | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q4 2020 | Q2 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Dec 31, 2020 | Jun 30, 2020 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | -100.00 % | -100.00 % |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 406.00 | 95.40 | 135.60 |
| Gross Profit | 0.00 | 0.00 | 0.00 | -406.00 | -95.40 | -135.60 |
| SG&A Expense | 53.37 K | 53.69 K | 54.04 K | 3.42 K | 105.44 K | 27.27 K |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 53.37 K | 53.69 K | 46.11 K | 3.42 K | 105.64 K | 29.35 K |
| Operating Income | -53.37 K | -53.69 K | -46.11 K | -3.83 K | -105.73 K | -29.49 K |
| Pretax Income | -79.18 K | -46.22 K | -75.23 K | -71.46 K | -8.50 M | -272.54 K |
| Tax Provision | 0.00 | -0.13 | 0.00 | 0.00 | 4.60 | 4.40 |
| Net Income | -79.18 K | -46.22 K | -75.23 K | -71.46 K | -8.50 M | -272.54 K |
| EPS (Basic) | 0.00 | -0.59 | -0.96 | 0.00 | -107.88 | -3.46 |
| EPS (Diluted) | 0.00 | -0.59 | -0.96 | 0.00 | -107.88 | -3.46 |
| Shares Outstanding | 0.00 | 78.75 K | 78.75 K | 0.00 | 78.75 K | 78.75 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.